Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesCL4H6 is an ionizable cationic lipid (apparent pKa = 6.35) that has been used in the generation of lipid nanoparticles (LNPs) encapsulating siRNA for use in vivo.1 LNPs containing CL4H6 and encapsulating siRNA targeting mRNA encoding Factor VII decrease hepatic levels of Factor VII in mice. LNPs containing CL4H6 and encapsulating a reporter protein selectively accumulate in the liver, spleen, and tumors over the lungs and kidneys, as well as selectively accumulate in tumor-associated macrophages (TAMs) over tumor cells, neutrophils, and other leukocytes, in an OS-RC-2 renal cancer mouse xenograft model after intravenous administration.2 LNPs containing CL4H6 and encapsulating siRNAs targeting mRNA encoding Stat3 and Hif-1α increase the levels of M1 macrophages in the tumor microenvironment and decrease tumor volume in the same model.2
WARNING This product is not for human or veterinary use.
1. Understanding structure-
2. Manipulating the function of tumor-